These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8820947)
1. The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer Institute. Donehower RC Stem Cells; 1996 Jan; 14(1):25-8. PubMed ID: 8820947 [TBL] [Abstract][Full Text] [Related]
2. The Clinical Development of Paclitaxel: A Successful Collaboration of Academia, Industry and the National Cancer Institute. Donehower RC Oncologist; 1996; 1(4):240-243. PubMed ID: 10387996 [TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
5. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
6. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute. Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691 [TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
9. The Antiepileptic Drug Development Program: an example of government-industry collaboration. White BG Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of esophageal cancer. Weiner LM Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790 [TBL] [Abstract][Full Text] [Related]
11. Review and outlook for the role of paclitaxel in urothelial carcinoma. Vaughn DJ Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793 [TBL] [Abstract][Full Text] [Related]
12. Future directions of paclitaxel-based therapy of breast cancer. Gianni L Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-91-S17-96. PubMed ID: 9374103 [TBL] [Abstract][Full Text] [Related]
13. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide. Minig L; Trimble EL; Birrer MJ; Kim KY; Takebe N; Abrams JS Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies. Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review. Holmes FA Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900 [TBL] [Abstract][Full Text] [Related]
16. Better infrastructure: industry-academia partnerships--a marriage of convenience? Abraham E Crit Care Med; 2009 Jan; 37(1 Suppl):S159-64. PubMed ID: 19104217 [TBL] [Abstract][Full Text] [Related]
17. The current state of adjuvant therapy for breast cancer: focus on paclitaxel. Hudis CA Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: breaking the barriers to harvest the crop. Pardoll D; Allison J Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404 [TBL] [Abstract][Full Text] [Related]
19. The evolving role of paclitaxel for patients with carcinoma of unknown primary site. Greco FA; Hainsworth JD Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795 [TBL] [Abstract][Full Text] [Related]
20. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]